CAD 0.04
(-20.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 15.3 Thousand CAD | -72.53% |
2022 | 55.7 Thousand CAD | 0.0% |
2021 | - CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - CAD | 0.0% |
2023 Q2 | 33.7 Thousand CAD | -19.58% |
2023 Q3 | 22.09 Thousand CAD | -34.46% |
2023 Q1 | 41.91 Thousand CAD | -24.75% |
2023 Q4 | 15.3 Thousand CAD | -30.74% |
2023 FY | 15.3 Thousand CAD | -72.53% |
2022 Q2 | - CAD | 0.0% |
2022 Q4 | 55.7 Thousand CAD | -16.2% |
2022 Q1 | - CAD | 0.0% |
2022 FY | 55.7 Thousand CAD | 0.0% |
2022 Q3 | 66.46 Thousand CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2021 FY | - CAD | 0.0% |
2021 Q4 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
BioMark Diagnostics Inc. | 454.15 Thousand CAD | 96.631% |
Sona Nanotech Inc. | 527.68 Thousand CAD | 97.101% |